STCube

STCube LT Debt/Equity

The Long-Term Debt to Equity Ratio of STCube (052020.KQ) as of Oct 16, 2026 is 0.09. In the previous year, Long-Term Debt to Equity Ratio was 0.03 — a change of 262.04% (higher).

LT Debt/Equity

0.09

YoY

262.04%

Last updated:

Long-Term Debt to Equity Ratio of STCube is 2024 0.09 . Long-Term Debt to Equity Ratio of STCube was 2023 0.03 . It decreases by 262.04% higher compared to the previous year.

The STCube LT Debt/Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

LT Debt/Equity
Date
LT Debt/Equity
Jan 1, 2017
0.00 KRW
Jan 1, 2018
0.30 KRW
Jan 1, 2019
0.04 KRW
Jan 1, 2020
0.03 KRW
Jan 1, 2021
0.04 KRW
Jan 1, 2022
0.02 KRW
Jan 1, 2023
0.03 KRW
Jan 1, 2024
0.09 KRW
The STCube LT Debt/Equity history
YEARLT Debt/EquityYoY
0.09+262.04%
0.03+24.40%
0.02-51.83%
0.04+39.94%
0.03-15.60%
0.04-88.18%
0.30—
0.00—
0.00-100.00%
0.08—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

STCube Stock analysis

What does STCube do? STCube Inc is a company based in Seoul, South Korea, operating within the Information Technology sector and Electrical Equipment industry. The company went public on July 5, 2001, with its ticker symbol 052020.KQ and ISIN KR7052020005. STCube Inc provides information technology services, focusing on the distribution of closed-circuit television (CCTV) lenses and related components. The company also engages in the development and licensing of immunomodulatory anticancer drug therapeutic candidates. STCube Inc's business is structured through two segments: the Information Technology segment, which handles the distribution of CCTV lenses and components, and the Biotechnology segment, which is involved in the development and licensing of drug candidates for cancer treatment. The company's official website is http://www.stcube.com/. STCube Inc is headquartered in Seoul, South Korea, and operates as a publicly traded entity on the Korean stock market. The company's activities span both technology and biotechnology fields, reflecting a diversified approach to product and service offerings in these sectors. The company's operations are centered around its headquarters in Seoul, with no additional locations specified in the provided information. STCube Inc's business model integrates IT services with biotechnology research and development, targeting both commercial and medical markets. STCube is one of the most popular companies on Eulerpool.

Frequently Asked Questions about STCube stock

Long-Term Debt to Equity Ratio of STCube is 0.09 in 2024.

Long-Term Debt to Equity Ratio of STCube changed from 0.03 to 0.09, representing a 262.04% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Long-Term Debt to Equity Ratio STCube since 2006 – with annual values, charts, and detailed analysis.

The LT Debt/Equity ratio measures long-term financial leverage. It shows how much permanent debt capital is used relative to equity financing.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Long-Term Debt to Equity Ratio's STCube with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — STCube

All Key Metrics — STCube